Lipitor as a Treatment for Alzheimer's Disease

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

NCT00141661 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

NCT00006187 ·Status: TERMINATED ·Phase: PHASE3

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

NCT00495417 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease

NCT00046358 ·Status: COMPLETED ·Phase: PHASE4

Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients

NCT00842920 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

NCT02547818 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

NCT02220738 ·Status: TERMINATED ·Phase: PHASE1

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

NCT06114745 ·Status: COMPLETED ·Phase: PHASE1

Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease

NCT02035982 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment

NCT03446001 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

NCT01466088 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

NCT00151333 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

NCT03518073 ·Status: COMPLETED ·Phase: PHASE2

Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers

NCT04570644 ·Status: COMPLETED ·Phase: PHASE1

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

NCT00633841 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia

NCT02569398 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Effect of LY450139 on the Long Term Progression of Alzheimer's Disease

NCT00594568 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease

NCT00459550 ·Status: COMPLETED ·Phase: PHASE1

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

NCT03748706 ·Status: COMPLETED ·Phase: PHASE2

Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease

NCT02811653 ·Status: UNKNOWN ·Phase: NA

Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease

NCT04149860 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease

NCT01482845 ·Status: COMPLETED ·Phase: PHASE1

Statins, Cholesterol and Cognitive Decline in Alzheimer's

NCT06635252 ·Status: COMPLETED

Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment

NCT02573740 ·Status: TERMINATED ·Phase: PHASE1

Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease

NCT00939822 ·Status: COMPLETED ·Phase: PHASE2